Engineering the transport of signaling molecules in glycosaminoglycan-based hydrogels

Signaling molecules are critically important to regulate cellular processes. Therefore, their incorporation into engineered biomaterials is indispensable for the applications in tissue engineering and regenerative medicine. In particular, the functionalization of highly hydrated polymer networks, so-called hydrogels, with the signaling molecules, has been quite beneficial to provide multiple cell-instructive signals. Following this strategy, the incorporation of sulfated glycosaminoglycans (GAGs) into such polymer networks offers unprecedented options to control the administration of signaling molecules via electrostatic interactions. Moreover, mathematical models can be instrumental in designing materials to tune the transport and adjust the local concentration of the signaling molecules to precisely modulate cell fate decisions. Accordingly, this study aims to systematically investigate the impact of different binary poly(ethylene glycol)-glycosaminoglycan hydrogel networks on the transport of signaling molecules by developing and applying mathematical modeling in combination with experimental approaches. The gained knowledge was then applied to modulate the bioactivities of pro-angiogenic growths factor within the binary hydrogel and rationally design a new class of cytocompatible GAG-based materials for the controlled administration of pro-angiogenic growth factors. Firstly, systematic studies on the mobility of signaling molecules within GAG-based polymer networks revealed differential effects of hydrogel network parameters such as mesh size, GAG content, and the sulfation pattern of the GAG building block on the transport of these signaling molecules. Secondly, the effect of the GAG content of the hydrogel and the sulfation pattern of the GAG building block on the bioactivity of hydrogel administrated vascular endothelial growth factor (VEGF) have been analyzed. Since VEGF is a GAG-affine protein that plays a major role in angiogenesis, its ability to promote vascular morphogenesis has been investigated. The simulation and experimental results demonstrated the determining impact of the availability of free (unbound) VEGF as well as the presence of GAGs with a specific sulfation pattern within the polymer network on the formation of the endothelial capillary network within the hydrogel. Finally, a rational design strategy has been applied to extend a GAG-hydrogel platform to allow for a far-reaching control of its cell instructive properties. The resulting materials are independently tunable over a broad range for their mechanical properties and GAG content. The GAG content of the hydrogel matrices, in particular, was shown to modulate the transport of pro-angiogenic growth factors most. Moreover, the hydrogel also supports endothelial vascular morphogenesis. In conclusion, the in here followed approach of combining experimental results and mathematical modeling for predicting the transport of signaling molecules and the rational design concept for customizing GAG-based hydrogel networks provide the fundamentals to precisely modulate cell fate decisions within GAG-based biohybrid polymer networks rationalizing their application for tissue engineering and regenerative medicin

Tuning the Local Availability of VEGF within Glycosaminoglycan-Based Hydrogels to Modulate Vascular Endothelial Cell Morphogenesis

Incorporation of sulfated glycosaminoglycans (GAGs) into cell-instructive polymer networks is shown to be instrumental in controlling the diffusivity and activity of growth factors. However, a subtle balance between local retention and release of the factors is needed to effectively direct cell fate decisions. To quantitatively unravel material characteristics governing these key features, the GAG content and the GAG sulfation pattern of star-shaped poly(ethylene glycol) (starPEG)–GAG hydrogels are herein tuned to control the local availability and bioactivity of GAG-affine vascular endothelial growth factor (VEGF165). Hydrogels containing varying concentrations of heparin or heparin derivatives with different sulfation pattern are prepared and thoroughly characterized for swelling, mechanical properties, and growth factor transport. Mathematical models are developed to predict the local concentration and spatial distribution of free and bound VEGF165 within the gel matrices. The results of simulation and experimental studies concordantly reveal how the GAG concentration and sulfation pattern determine the local availability of VEGF165 within the cell-instructive hydrogels and how the factor—in interplay with cell-instructive gel properties—determines the formation and spatial organization of capillary networks of embedded human vascular endothelial cells. Taken together, this study exemplifies how mathematical modeling and rational hydrogel design can be combined to pave the way for precision tissue engineering. © 2020 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinhei

Engineering the transport of signaling molecules in glycosaminoglycan-based hydrogels

Signaling molecules are critically important to regulate cellular processes. Therefore, their incorporation into engineered biomaterials is indispensable for the applications in tissue engineering and regenerative medicine. In particular, the functionalization of highly hydrated polymer networks, so-called hydrogels, with the signaling molecules, has been quite beneficial to provide multiple cell-instructive signals. Following this strategy, the incorporation of sulfated glycosaminoglycans (GAGs) into such polymer networks offers unprecedented options to control the administration of signaling molecules via electrostatic interactions. Moreover, mathematical models can be instrumental in designing materials to tune the transport and adjust the local concentration of the signaling molecules to precisely modulate cell fate decisions. Accordingly, this study aims to systematically investigate the impact of different binary poly(ethylene glycol)-glycosaminoglycan hydrogel networks on the transport of signaling molecules by developing and applying mathematical modeling in combination with experimental approaches. The gained knowledge was then applied to modulate the bioactivities of pro-angiogenic growths factor within the binary hydrogel and rationally design a new class of cytocompatible GAG-based materials for the controlled administration of pro-angiogenic growth factors. Firstly, systematic studies on the mobility of signaling molecules within GAG-based polymer networks revealed differential effects of hydrogel network parameters such as mesh size, GAG content, and the sulfation pattern of the GAG building block on the transport of these signaling molecules. Secondly, the effect of the GAG content of the hydrogel and the sulfation pattern of the GAG building block on the bioactivity of hydrogel administrated vascular endothelial growth factor (VEGF) have been analyzed. Since VEGF is a GAG-affine protein that plays a major role in angiogenesis, its ability to promote vascular morphogenesis has been investigated. The simulation and experimental results demonstrated the determining impact of the availability of free (unbound) VEGF as well as the presence of GAGs with a specific sulfation pattern within the polymer network on the formation of the endothelial capillary network within the hydrogel. Finally, a rational design strategy has been applied to extend a GAG-hydrogel platform to allow for a far-reaching control of its cell instructive properties. The resulting materials are independently tunable over a broad range for their mechanical properties and GAG content. The GAG content of the hydrogel matrices, in particular, was shown to modulate the transport of pro-angiogenic growth factors most. Moreover, the hydrogel also supports endothelial vascular morphogenesis. In conclusion, the in here followed approach of combining experimental results and mathematical modeling for predicting the transport of signaling molecules and the rational design concept for customizing GAG-based hydrogel networks provide the fundamentals to precisely modulate cell fate decisions within GAG-based biohybrid polymer networks rationalizing their application for tissue engineering and regenerative medicin

Engineering the transport of signaling molecules in glycosaminoglycan-based hydrogels

Signaling molecules are critically important to regulate cellular processes. Therefore, their incorporation into engineered biomaterials is indispensable for the applications in tissue engineering and regenerative medicine. In particular, the functionalization of highly hydrated polymer networks, so-called hydrogels, with the signaling molecules, has been quite beneficial to provide multiple cell-instructive signals. Following this strategy, the incorporation of sulfated glycosaminoglycans (GAGs) into such polymer networks offers unprecedented options to control the administration of signaling molecules via electrostatic interactions. Moreover, mathematical models can be instrumental in designing materials to tune the transport and adjust the local concentration of the signaling molecules to precisely modulate cell fate decisions. Accordingly, this study aims to systematically investigate the impact of different binary poly(ethylene glycol)-glycosaminoglycan hydrogel networks on the transport of signaling molecules by developing and applying mathematical modeling in combination with experimental approaches. The gained knowledge was then applied to modulate the bioactivities of pro-angiogenic growths factor within the binary hydrogel and rationally design a new class of cytocompatible GAG-based materials for the controlled administration of pro-angiogenic growth factors. Firstly, systematic studies on the mobility of signaling molecules within GAG-based polymer networks revealed differential effects of hydrogel network parameters such as mesh size, GAG content, and the sulfation pattern of the GAG building block on the transport of these signaling molecules. Secondly, the effect of the GAG content of the hydrogel and the sulfation pattern of the GAG building block on the bioactivity of hydrogel administrated vascular endothelial growth factor (VEGF) have been analyzed. Since VEGF is a GAG-affine protein that plays a major role in angiogenesis, its ability to promote vascular morphogenesis has been investigated. The simulation and experimental results demonstrated the determining impact of the availability of free (unbound) VEGF as well as the presence of GAGs with a specific sulfation pattern within the polymer network on the formation of the endothelial capillary network within the hydrogel. Finally, a rational design strategy has been applied to extend a GAG-hydrogel platform to allow for a far-reaching control of its cell instructive properties. The resulting materials are independently tunable over a broad range for their mechanical properties and GAG content. The GAG content of the hydrogel matrices, in particular, was shown to modulate the transport of pro-angiogenic growth factors most. Moreover, the hydrogel also supports endothelial vascular morphogenesis. In conclusion, the in here followed approach of combining experimental results and mathematical modeling for predicting the transport of signaling molecules and the rational design concept for customizing GAG-based hydrogel networks provide the fundamentals to precisely modulate cell fate decisions within GAG-based biohybrid polymer networks rationalizing their application for tissue engineering and regenerative medicin

Kanser tedavisi için anti-epidermal büyüme faktör reseptör hedefli immünolipozomlar ile celecoxib salınımı.

Millions of people are affected by retinal diseases such as age-related macular degeneration (AMD) and retinitis pigmentosa (RP, night blindness). Retinal tissue engineering has potential to become a valid therapeutic approach to regenerate retina. The aim of this study was to construct a biomimetic retinal tissue substitute by using biocompatible and natural polymers and in vitro techniques. For this purpose, a retinal pigment epithelial (RPE) cell monolayer was formed on an electrospun silk fibroin mesh to mimic Bruch’s membrane. Results showed that RPE could proliferate and form a cell layer on the fibroin mesh. A HUVEC layer was constructed separately by microfabrication of a fractal tree design using photocrosslinkable methacrylated hyaluronic acid (HAMA) hydrogel to mimic the vasculature of choroid. To improve HUVEC adhesion in the design methacrylated collagen and methacrylated gelatin were immobilized in them using photolithography. It was seen that HUVEC could adhere only on the microchannels of the pattern and, form tubular structures at late culture periods. The co-culture studies in non-contact mode due to separation of the two cell types by the fibrous mat demonstrated that RPE cells on Bruch’s membrane could change the cell morphology, proliferation and thickness of vascular pattern that was formed by HUVECs in microchannels.M.S. - Master of Scienc

FUNCTIONAL APPLICATION OF IMMUNOLIPOSOMES ENCAPSULATING CELECOXIB ON COLON CANCER CELL LINES

FUNCTIONAL APPLICATION OF IMMUNOLIPOSOMES ENCAPSULATING CELECOXIB ON COLON CANCER CELL LINE

Epidermal growth factor receptor-targeted immunoliposomes for delivery of celecoxib to cancer cells

Cyclooxygenase-2 (COX-2) is highly expressed in many different cancers. Therefore, the inhibition of the COX-2 pathway by a selective COX-2 inhibitor, celecoxib (CLX), may be an alternative strategy for cancer prevention and therapy. Liposomal drug delivery systems can be used to increase the therapeutic efficacy of CLX while minimizing its side effects. Previous studies have reported the encapsulation of CLX within the non-targeted long circulating liposomes and functional effect of these formulations against colorectal cancer cell lines. However, the selectivity and internalization of CLX-loaded liposomes can further be improved by grafting targeting ligands on their surface. Cetuximab (anti-epidermal growth factor receptor - EGFR - monoclonal antibody) is a promising targeting ligand since EGFR is highly expressed in a wide range of solid tumors. The aim of this study was to develop EGFR-targeted immunoliposomes for enhancing the delivery of CLX to cancer cells and to evaluate the functional effects of these liposomes in cancer cell lines. EGFR-targeted ILs, having an average size of 120 nm, could encapsulate 40% of the CLX, while providing a sustained drug release profile. Cell association studies have also shown that the immunoliposome uptake was higher in EGFR-overexpressing cells compared to the non-targeted liposomes. In addition, the CLX-loaded-anti-EGFR immunoliposomes were significantly more toxic compared to the non-targeted ones in cancer cells with EGFR-overexpression but not in the cells with low EGFR expression, regardless of their COX-2 expression status. Thus, selective targeting of CLX with anti-EGFR immunoliposomes appears to be a promising strategy for therapy of tumors that overexpress EGFR

In Vitro Characterization of a Liposomal Formulation of Celecoxib Containing 1,2-Distearoyl-sn-Glycero-3-Phosphocholine, Cholesterol, and Polyethylene Glycol and its Functional Effects Against Colorectal Cancer Cell Lines

Nanosized liposomal drug delivery systems are well suited for selective drug delivery at tumor sites. Celecoxib (CLX) is a highly hydrophobic cyclooxygenase-2 inhibitor that can reduce the incidence of colorectal polyps; however, the adverse cardiovascular effects limit its applicability. Here, we report a liposomal formulation of CLX using 1,2-Distearoyl-sn-glycero-3-phosphocholine, cholesterol, and polyethylene glycol. Encapsulation efficiency of the drug was greater than 70%; the release was slow and sustained with only 12%-20% of CLX released in the first 12h. Flow cytometry and confocal microscopy studies using the colon cancer cell lines HCT-116 and SW620 showed significantly higher cellular association and internalization of the liposomes after incubation for 6h when compared with 30min. The liposomes did not colocalize with transferrin, but had a punctuate appearance, indicating vesicular localization. Cell proliferation was inhibited by 95% and 78%, respectively, in SW620 and HT29 cells after incubation with 600M liposomal CLX for 72h. Moreover, cellular motility, as shown by a scratch wound healing assay, was also significantly (p=0.006) inhibited when SW620 cells were incubated with 400M liposomal CLX. This is the first report of the successful encapsulation of CLX in a long-circulating liposomal formulation that could be effective against colorectal cancer. (c) 2013 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 102:3666-3677, 201